Skip to main content
Clinical Trials/JPRN-jRCT2080224161
JPRN-jRCT2080224161
Completed
N/A

An exploratory clinical trial to evaluate the efficacy and safety of the CCI Kit in patients with knee joint cartilage defects.

Interstem CO .,Ltd0 sites36 target enrollmentNovember 26, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Traumatic cartilage defect of the knee joint and osteochondritis dissecans
Sponsor
Interstem CO .,Ltd
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 26, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Interstem CO .,Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients diagnosed with traumatic cartilage defect of the knee joint and osteochondritis dissecans
  • 2\)Patients applying microfractures
  • 3\)Patients with clinical symptoms in the knee joint
  • 4\)Patients with KOOS 5 of 70 or less at screening
  • 5\)Patients with a cartilage defect area from 2 cm2 to 9 cm2

Exclusion Criteria

  • 1\)Patients diagnosed with osteoarthritis and patients with Kellgren\-Lawrence classification stage 2 or higher
  • 2\)Patients with inflammatory arthritis associated with autoimmune diseases such as rheumatoid arthritis
  • 3\)Patients with cartilage defect in both knee joints
  • 4\)Patients with multiple cartilage defect
  • 5\)Patients with a bone defect with a depth of 8 mm or more at the cartilage defect site
  • 6\)Patients who have a history of surgery for adjustment of joint alignment or who need it

Outcomes

Primary Outcomes

Not specified

Similar Trials